Live Analyst Rating Changes 54062 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David Saxon
NDM

David Saxon

Needham
Wall Street Analyst
★★★★★
#228
on 13Foresight · ranked by our own returns
61%
Success Rate
+31.9%
Average Return
33 of 54 calls profitable · +30.0% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 61% of David Saxon's ratings turned a profit when each position was held for 1 year — averaging +31.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

68 Buy 37 Hold 0 Sell
David's Stock Coverage 20 ratings · 2026-11-04
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ATEC
Alphatec Holdings
 Oct 30, 2026 BUY Strong Buy
+116.9% avg upside
23 analysts
$12.00
70.37% Upside
 +17.6% ·
GKOS
Glaukos
 Oct 29, 2026 BUY Strong Buy
-18.6% avg upside
21 analysts
$251.00
5.56% Upside
 -3.9% ·
ALGN
Align Tech
 Oct 29, 2026 HOLD Buy
+89.9% avg upside
21 analysts
 — -1.4% ·
CH:ALC
Alcon
 Oct 21, 2026 BUY Strong Buy
+19.4% avg upside
36 analysts
$80.74
36.71% Upside
 +2.2% ·
GEHC
GE Healthcare Technologies Inc
 Oct 05, 2026 BUY Strong Buy
+10.2% avg upside
23 analysts
$93.00
21.44% Upside
 +30.6% ·
IRTC
Irhythm Technologies
 Oct 05, 2026 BUY Strong Buy
+32.2% avg upside
21 analysts
$194.00
57.26% Upside
 +15.8% ·
NVST
Envista Holdings
 Sep 24, 2026 HOLD Buy
+27.3% avg upside
19 analysts
 — +11.1% ·
BFLY
Butterfly Network
 Sep 22, 2026 BUY Strong Buy
+24.7% avg upside
11 analysts
$10.00
56.54% Upside
 -38.0% ·
IRMD
Iradimed
 Sep 22, 2026 HOLD Strong Buy
+9.1% avg upside
7 analysts
 — -6.2% ·
AZTA
Azenta
 Sep 14, 2026 BUY Buy
+24.4% avg upside
13 analysts
$37.00
5.27% Downside
 +15.9% ·
COO
Cooper Co
 Sep 10, 2026 BUY Buy
+105.8% avg upside
21 analysts
$73.00
22.69% Upside
 +11.4% ·
STAA
Staar Surgical
 Aug 13, 2026 HOLD Buy
+42.3% avg upside
16 analysts
 — -3.1% ·
XRAY
DENTSPLY SIRONA
 Aug 07, 2026 HOLD Buy
+182.3% avg upside
25 analysts
 — +12.0% ·
CYRX
CryoPort
 Aug 07, 2026 BUY Strong Buy
-4.1% avg upside
15 analysts
$19.00
9.98% Upside
 +7.3% ·
GMED
Globus Medical
 Aug 07, 2026 BUY Strong Buy
+18.8% avg upside
24 analysts
$117.00
49.82% Upside
 -3.4% ·
RXST
RxSight
 Aug 06, 2026 BUY Hold
+85.9% avg upside
13 analysts
$11.00
125.88% Upside
 -19.9% ·
CARL
Carlsmed, Inc.
 Aug 06, 2026 BUY Strong Buy
+25.4% avg upside
6 analysts
$17.00
13.69% Upside
 +5.1% ·
SGHT
Sight Sciences
 Aug 06, 2026 HOLD Buy
+9.7% avg upside
14 analysts
 — +32.9% ·
SIBN
SI-Bone
 Aug 04, 2026 BUY Strong Buy
+22.8% avg upside
18 analysts
$27.00
27.13% Upside
 +15.1% ·
BLCO
Bausch + Lomb Corporation
 Jul 29, 2026 HOLD Buy
+7.5% avg upside
20 analysts
 — +27.2% ·
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David Saxon — Frequently Asked Questions
How accurate are David Saxon's stock ratings?
Based on the calls 13Foresight could measure, about 61% of David's ratings were profitable over a one-year hold, with an average return of +31.7% per rating, or +30.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is David ranked on 13Foresight?
David Saxon is currently ranked #228 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on ATEC, GKOS, ALGN, CH:ALC, GEHC, IRTC, NVST, BFLY, IRMD, AZTA, COO, STAA and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.